These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985 [TBL] [Abstract][Full Text] [Related]
7. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Xiao G; Zhu S; Xiao X; Yan L; Yang J; Wu G Hepatology; 2017 Nov; 66(5):1486-1501. PubMed ID: 28586172 [TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis markers of nonalcoholic steatohepatitis. Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988 [TBL] [Abstract][Full Text] [Related]
9. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis. Golabi P; Sayiner M; Fazel Y; Koenig A; Henry L; Younossi ZM Expert Rev Gastroenterol Hepatol; 2016; 10(1):63-71. PubMed ID: 26469309 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. Tsai E; Lee TP Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062 [TBL] [Abstract][Full Text] [Related]
11. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. Alkhouri N; Sedki E; Alisi A; Lopez R; Pinzani M; Feldstein AE; Nobili V Liver Int; 2013 Jan; 33(1):79-85. PubMed ID: 23146095 [TBL] [Abstract][Full Text] [Related]
12. Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms. Lykiardopoulos B; Hagström H; Fredrikson M; Ignatova S; Stål P; Hultcrantz R; Ekstedt M; Kechagias S PLoS One; 2016; 11(12):e0167776. PubMed ID: 27936091 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease. Kalveram L; Baumann U; De Bruyne R; Draijer L; Janczyk W; Kelly D; Koot BG; Lacaille F; Lefere S; Lev HM; Lubrecht J; Mann JP; Mosca A; Rajwal S; Socha P; Vreugdenhil A; Alisi A; Hudert CA; J Pediatr Gastroenterol Nutr; 2024 Jan; 78(1):27-35. PubMed ID: 38291699 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study. Cui J; Heba E; Hernandez C; Haufe W; Hooker J; Andre MP; Valasek MA; Aryafar H; Sirlin CB; Loomba R Hepatology; 2016 Feb; 63(2):453-61. PubMed ID: 26560734 [TBL] [Abstract][Full Text] [Related]
15. Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population. Pérez-Gutiérrez OZ; Hernández-Rocha C; Candia-Balboa RA; Arrese MA; Benítez C; Brizuela-Alcántara DC; Méndez-Sánchez N; Uribe M; Chávez-Tapia NC Ann Hepatol; 2013; 12(3):416-24. PubMed ID: 23619258 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes. Pennisi G; Enea M; Falco V; Aithal GP; Palaniyappan N; Yilmaz Y; Boursier J; Cassinotto C; de Lédinghen V; Chan WK; Mahadeva S; Eddowes P; Newsome P; Karlas T; Wiegand J; Wong VW; Schattenberg JM; Labenz C; Kim W; Lee MS; Lupsor-Platon M; Cobbold JFL; Fan JG; Shen F; Staufer K; Trauner M; Stauber R; Nakajima A; Yoneda M; Bugianesi E; Younes R; Gaia S; Zheng MH; Cammà C; Anstee QM; Mózes FE; Pavlides M; Petta S Hepatology; 2023 Jul; 78(1):195-211. PubMed ID: 36924031 [TBL] [Abstract][Full Text] [Related]
18. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. Staufer K; Halilbasic E; Spindelboeck W; Eilenberg M; Prager G; Stadlbauer V; Posch A; Munda P; Marculescu R; Obermayer-Pietsch B; Stift J; Lackner C; Trauner M; Stauber RE United European Gastroenterol J; 2019 Oct; 7(8):1113-1123. PubMed ID: 31662868 [TBL] [Abstract][Full Text] [Related]
19. AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. Peleg N; Issachar A; Sneh-Arbib O; Shlomai A Dig Liver Dis; 2017 Oct; 49(10):1133-1138. PubMed ID: 28572039 [TBL] [Abstract][Full Text] [Related]
20. Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016. Kaswala DH; Lai M; Afdhal NH Dig Dis Sci; 2016 May; 61(5):1356-64. PubMed ID: 27017224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]